Humira Prices, Coupons, Copay & Patient Assistance

Print

Save

Humira
(adalimumab)

is a member of the antirheumatics drug class and is commonly used for
Ankylosing Spondylitis, Crohn’s Disease, Crohn’s Disease – Acute, and others.

The cost for Humira subcutaneous kit (40 mg/0.4 mL) is around $7,299 for a supply of 2 kits, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Humira prices

Subcutaneous Kit

Quantity	Per unit	Price
2	$3,649.51	$7,299.02

Important: When there is a range of pricing, consumers should normally expect to pay the lower price.
However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Quantity	Per unit	Price
2	$3,649.51	$7,299.02

Important: When there is a range of pricing, consumers should normally expect to pay the lower price.
However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Quantity	Per unit	Price
2	$7,294.29	$14,588.57

Important: When there is a range of pricing, consumers should normally expect to pay the lower price.
However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Humira Coupons, Copay Cards and Rebates

Humira offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples.
Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining
a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines,
over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy,
Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Humira Complete Savings Card

Eligible commercially insured patients may pay as little as $5 per monthly prescription; for additional information contact the program at 800-448-6472.

Applies to:

Humira

Number of uses:

per prescription per calendar year

Form more information phone: 800-448-6472 or
Visit website

Humira Complete Savings Card Rebate

If your pharmacy does not accept the Savings Card eligible commercially insured patients may qualify for a rebate for the out-of-pocket cost after the patient paid in full for their prescription; for additional information contact the program at 800-448-6472.

Applies to:

Humira

Number of uses:

One rebate per prescription fill

Form more information phone: 800-448-6472 or
Visit website

Humira Extra Help Subsidy

Patients who have Medicare Part D coverage may be eligible to apply for the Part D Extra Help Subsidy and once accepted to the program may pay $8.25 or less per monthly prescription; for additional information contact the program at 800-448-6472.

Applies to:

Humira

Number of uses:

Per prescription until program expires

Form more information phone: 800-448-6472 or
Visit website

Patient Assistance & Copay Programs for Humira

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines,
as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria.
Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:

1. *See Additional Information section below
2. Between 400-500% of FPL
3. FDA Approved Diagnosis – See Program Website for Details
4. Must reside and receive treatment in US
5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

• Humira
  (adalimumab)
  Injection; Subcutaneous

More information please phone:
866-316-7263
Visit Website

Provider: myAbbVie Assist for Humira

Eligibility requirements:

1. Must be uninsured or underinsured
2. At or below 600% of FPL
3. Not applicable
4. Must reside in the US and be under the direct care of a US physician
5. Any patient who requires the medication and are in need should call the company. Eligibility determined on a case-by-case basis. Patients with prescription drug coverage may be eligible on exception basis.

Applicable drugs:

• Humira
  (adalimumab)
  Injection; Subcutaneous

More information please phone:
800-222-6885
Visit Website

More about Humira (adalimumab)

• Check interactions
• Compare alternatives
• Reviews (669)
• Drug images
• Side effects
• Dosage information
• Patient tips
• During pregnancy
• Support group
• FDA approval history
• Drug class: antirheumatics
• Breastfeeding
• En español

Patient resources

• Drug Information
• Humira Pediatric Crohns Start
• Humira Pen
• Humira Pen-CD/UC/HS Starter
• Humira Pen-Ps/UV Starter

Other brands

Amjevita, Hadlima, Idacio, Yusimry, . .. +5 more

Professional resources

• Prescribing Information

Related treatment guides

• Crohn’s Disease, Maintenance
• Ankylosing Spondylitis
• Crohn’s Disease
• Crohn’s Disease, Acute

How much does Humira cost without insurance?

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on April 10, 2023.

The average cash price of Humira (generic name: adalimumab) without insurance is around $6,240 for 1 carton (2 pens) of 40 mg/0.4 mL using an online coupon, but most people do not pay this much. Your actual cost will depend upon which Humira product you need and the strength, if you have insurance, and your specific type of insurance.

Online coupons or copay cards may be useful if you are paying cash and not using insurance to cover your prescription. Keep in mind these prices are always subject to change.

Cash prices vary greatly among US pharmacies, even in the same city. It may be helpful to check the prices at several pharmacies if you are paying cash for your Humira prescription.

Related: View Humira Prices, Coupons and Patient Assistance Programs

If you are receiving Humira from a specialty pharmacy, be sure to also ask about using any copay cards, coupons or other discounts. This may lower your out-of-pocket costs, like copays. Specialty pharmacies often handle complex biologics like Humira. Specialty drugs may need special handling such as refrigeration, fast shipping, or additional monitoring by a health care provider for side effects.

Who can I call about getting Humira?

AbbVie provides insurance specialists from their Humira website to help guide you through coverage and access if you are prescribed Humira and do not have insurance.

To get further information about how to obtain Humira, you can call AbbVie at 1-800-448-6472 (1-800-4HUMIRA).

Can I get Humira if I don’t have insurance?

No insurance or unemployed

• If you do not have insurance or are unemployed, you may be eligible to receive Humira at no cost from the AbbVie Patient Assistance Program (myAbbVie Assist) or another foundation if you meet certain income criteria.
• According to AbbVie, financial need requirements will vary by medicine. Your eligibility may be based on your insurance coverage, household income, and projected out-of-pocket medical expenses.
• Other groups, such as nonprofit organizations, may be able to provide financial support for your medications. Talk to your health care provider about ways to afford your medication.

Does Medicaid cover Humira?

Medicaid

• Medicaid is a US government-run health insurance program that provides medical assistance for low-income individuals and families, or people with certain disabilities
• It is jointly run by the federal government and individual US states. State Medicaid programs may provide coverage for Humira but it can vary based on your state.
• To find out specific Humira coverage for a particular state Medicaid program, you can contact AbbVie at 1-800-448-6472.

Does Medicare cover Humira?

Medicare

Medicare is a US federal health insurance program for people 65 and older and those with certain disabilities. With Medicare, prescription coverage for Humira is available through many Medicare Advantage Plans and Medicare Supplemental Plans but you must enroll for these add-on plans separately.

• Medicare Advantage Plans (Part C) – Medicare Advantage Plans provide hospital and medical insurance, and generally includes prescription coverage.

• Supplemental Plans (Part D) – A separate prescription coverage option that you can add to Medicare. You may be eligible to receive a low income subsidy (Extra Help) as well to help pay for Humira.

• If you have Medicare Advantage or Medicare Part D, most plans will cover Humira with a copay.

Does my insurance cover Humira?

Commercial Insurance

The manufacturer of Humira, AbbVie, has a Copay Savings Card program in place to help you afford Humira if you have commercial insurance (i.e., through your employer or purchased through the Affordable Care Act). The co-pay assistance program is not available to patients with federal, state, or government-funded insurance programs.

While your insurance may help cover a portion of Humira cost, your copay may be unaffordable for you. In these circumstances the copay card can be used to help lower these costs.

The Humira Copay Savings card may reduce your out-of-pockets expenses to a little as $5 per prescription, but may have a maximum annual savings. These copay cards do not have an expiration date but you may need to re-enroll each year.

• In 2019, 94% of eligible patients with a Humira copay saving card received their Humira for $5 per month, every month.
• In 2021, more than 95% of commercial and Medicare Part D patients have coverage for Humira as a preferred, first-line medication on the insurance plans formulary.
• Contact AbbVie at 1-800-448-6472 to learn more.

What is Humira?

Humira is a biologic injectable protein known as a monoclonal antibody. It is used to treat many different autoimmune-types of diseases where inflammation leads to symptoms. It’s classified as a Tumor Necrosis Factor (TNF) alpha inhibitor, and binds to and blocks the action of TNF in our body to lower inflammation.

Humira has been developed through genetic engineering, and that is one reason it is so expensive. Humira has been one of the world’s best selling drugs for many years. It is given as a self-administered subcutaneous injection (under the skin).

Because Humira blocks the inflammatory process, it has a place in many autoimmune conditions with inflammation as a central mechanism, including:

• Rheumatoid arthritis
• Juvenile arthritis
• Ankylosing spondylitis
• Crohn’s disease
• Plaque psoriasis
• Ulcerative colitis
• Psoriatic arthritis
• Hidradenitis Suppurativa
• Uveitis

Is there a generic for Humira?

There is not a commercially available biosimilar option for Humira at this time. Several biosimilars for Humira have been approved by the FDA, but are not yet on the market.

In late 2016, the original Humira original patent expired opening doors for biosimilar development. Due to patents and other legal issues, these lower cost biosimilar products are not expected to become commercially available until 2023.

A biosimilar is a biological product that is very similar to a reference biologic and for which there are no clinically meaningful differences in terms of safety, purity, and potency. Humira cannot have an exact generic copy due to manufacturing differences inherent for biological products.

If you need further information about how to obtain Humira, you can call AbbVie at 1.800.4HUMIRA (1.800.448.6472).

This is not all the information you need to know about Humira (adalimumab) for safe and effective use. Review the full Humira information here, and discuss this information with your doctor or other health care provider.

References

• Humira Injection [package insert]. North Chicago, IL: AbbVie Inc. Accessed March 25, 2021 at https://www.humira.com/humira-complete/insurance-coverage-explained
• Humira Price Guide. Drugs.com. Accessed March 25, 2021 at https://www.drugs.com/price-guide/humira

Related medical questions

• What happens when you stop taking Humira?
• What are the new drugs for the treatment of rheumatoid arthritis (RA)?
• What are monoclonal antibodies?
• Does Humira cause weight gain or weight loss?
• How long does it take for Humira to work?
• What are biosimilar drugs?
• How long can Humira be out of the fridge?
• What food should I avoid while taking Humira?
• How long can you stay on Humira?
• What causes Plaque Psoriasis?
• Can you drink alcohol while taking Humira?

Drug information

• Humira Information for Consumers
• Humira prescribing info & package insert
  (for Health Professionals)
• Side Effects of Humira
  (detailed)

Related support groups

• Humira
  (68 questions, 368 members)

Medical Disclaimer

HUMIRA prices in Moscow pharmacies

from 22,500 to 124,000 rubles

Release form

capsules 550 mg 30 pcs

HUMIRA available found in 8 pharmacies in Moscow

Public

Humira injections 40mg 0. 4 ml №2 Abbvie / Vetter Pharma-Fertigung, Germany 31.900 ⁰⁰

Buy at pharmacy 900 50 Pre-book price 31.900 ⁰⁰

public SITE 9000 3

Viber

directions Route

HUMIRA injection solution 20mg/0.2ml syringe in set. with napkins №2 AbbVie Biopharmaceuticals (Switzerland) 70,000 ⁰⁰ HUMIRA injection solution 40mg/0 ,4ml syringe included. with wipes №2 AbbVie Biopharmaceuticals (Switzerland) injection 20mg/0.2ml syringe included. with napkins No. 2 according to the Turbo program card Abbvie 59.500 ⁰⁰ HUMIRA injection solution 40mg/0. 4ml syringe incl. with napkins №2 according to the Turbo program card Abbvie 102.900 ⁰⁰ 90 022 phone CALL directions Route

Humira rr d/i s/c 40mg/0.4ml spr comp salf sp 0.4ml N2x1 Vetter Pharma/Ortat GER GER, Wetter Pharma/Ortat 22.500 ⁰⁰ public 900 23 SITE phone CALL directions Route

HUMIRA 40mg/0.4ml N2 subcutaneous solution Vetter Pharma-Fertigung GmbH & Co.KG Vetter Pharma-Fertigung 57,000 ⁰⁰ HUMIRA 40mg/0.8ml 0.8ml N 2 solution for subcutaneous injection Wetter Pharma-Fertigung GmbH and Co. KG 9 syringe0035 Vetter Pharma-Fertigung 57,000 ⁰⁰ HUMIRA 40mg/0.8ml 0.8ml N1 solution for subcutaneous injection Vetter Pharma-Fertigung GmbH & Co. KG Vetter Pharma-Fertigung 28.500 ⁰⁰ 9 0019

phone CALL directions Route

Humira N2 solution d/i p/c 40mg/0.4ml spr comp salf sp 0. 4ml Wetter Pharma-Fertigung Germany 22.500 ⁰⁰ public SITE phone CALL 90 022 directions Route

Humira solution d/i p/c 40mg/0.4ml spr comp salf sp 0.4ml N2x1 Vetter Pharma/Abbwee GER 44. 100 ⁰⁰ Humira solution for and s.c.0029

44.100 ⁰⁰ public SITE phone CALL 90 022 directions Route

Humira solution d/i s/c 40mg/0.8ml spr comp salf sp 0.8ml N1x1 29,000 9004 0 00 phone CALL directions Route

9002 9

Humira solution d/i s/c 40mg/0.4ml spr comp sulf sp 0.4ml N2x1 Vetter Pharma/Ortat GER 44.100 ⁰⁰ 9 0032 Humira solution for s.c. 40mg/0.4ml spr comp saf sp 0.4ml N2x1 Vetter Pharma/AbbWee GER 44. 100 ⁰⁰

90 030

HUMIRA reviews

5.0

1 review 03 Arthritis injections

Humira is one of those remedies that effectively copes with the treatment of rheumatoid arthritis. These are injections that need to be done twice a month. But one minus of this drug is the price of treatment with Humira injections. Unfortunately, not everyone can help themselves. But it’s good that there are some government programs for which the drug … More

Useful review? 61

Read all reviews

Analogs

Analogs are selected according to the active substance, indication and method of application

More analogs

Instruction

Humira is a selective immunosuppressant. Pharmacological properties Adalimumab is obtained by recombination using human monoclonal antibodies. Peptide sequences in a molecule are of anthropological origin only. The adalimumab molecule has a high degree of affinity for TNF-α (tumor necrosis factor). With TNF-β binding is not observed. When bound to tumor necrosis factor,…

Read more

How a pharmaceutical company made $114 billion on evergreen patents fixing the high price of the drug and limiting competition.

Write to itpc-eeca.org.

AbbVie holds the patent for the anti-inflammatory drug Humira, which is used to treat arthritis. The drug was approved back in 2002, and generic versions of the drug were supposed to become available in 2016. Why didn’t this happen?

In 2016, the patent for the base substance adalimumab expired and regulators approved Amgen’s generic Amjevita, as well as other generics. However, AbbVie used the US patent system to its advantage and blocked competitors from entering the market. AbbVie is suing Amgen, alleging that it infringes on 10 of its patents. Amgen argued that most of AbbVie’s patents were invalid, but the parties reached a settlement agreement in which Amgen agreed not to start selling its drug until 2023.

Over the next five years, AbbVie entered into similar agreements with nine other manufacturers who wanted to release their own versions of Humira. They all agreed to delay the market launch until 2023. Since then, AbbVie has earned $114 billion.

It is worth noting that such games with patent protection are not new to the pharmaceutical industry. Following the example of AbbVie, Amgen has accumulated secondary patents for its anti-inflammatory drug Enbrel, delaying the generic version by 13 years. Merck and its partners by some count have received 180 patents for their cancer-fighting drug Keytruda, and a new formula is being developed that could further extend the monopoly.

Over the past 20 years, AbbVie has raised the price of Humira about 30 times, most recently by 8 percent in January 2023. Since the end of 2016, the price of the drug has risen 60 percent to over $80,000 a year, according to research firm SSR Health. Another analysis found that Medicare, which covered 42,000 patients for Humira in 2020, spent $2. 2 billion more on the drug from 2016 to 2019 than it could have had competitors enter the market. Patients also said that because of the high price of the drug, they had to refuse treatment or postpone retirement.

In 2021, Humira’s sales accounted for more than a third of AbbVie’s total revenue, and over the entire period of the monopoly, the drug has brought the company about 208 billion US dollars.

In 2010, the Affordable Care Act created a pathway for the approval of so-called biosimilars, which compete with complex biological drugs such as Humira, which are made inside living cells. Unlike generic counterparts to traditional synthetic drugs, biosimilars are usually not identical to their brand-name drugs and cannot be replaced by a pharmacist.

It was hoped that biosimilars would drastically reduce the cost of expensive branded biologics. This is exactly what happened in Europe, but in the United States things have turned out differently – pharmaceutical companies have turned patents into a weapon against competition.